The Vanguard Group 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Axsome Therapeutics, Inc. AXSM |
The Vanguard Group | 3,696,766 7.810% |
279,138 (+8.17%) |
Filing |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Axsome Therapeutics, Inc. AXSM |
The Vanguard Group | 3,417,628 7.870% |
732,006 (+27.26%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
The Vanguard Group | 2,685,622 7.130% |
44,548 (+1.69%) |
Filing |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
The Vanguard Group | 2,641,074 7.070% |
2,641,074 (New Position) |
Filing |